Trial Profile
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With Congestive Heart Failure (CHF) and Renal Impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Furosemide (Primary) ; Rolofylline (Primary)
- Indications Heart failure; Renal impairment
- Focus Pharmacodynamics
- Sponsors NovaCardia
- 24 Mar 2010 'Merck and Co' added as trial sponsor as reported by ClinicalTrials.gov.
- 06 Nov 2005 New trial record.